Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing follows a step-up schedule that most patients begin at 0.25 mg weekly, then advance by 0.25 mg increments every seven days until reaching their maintenance dose. This gradual titration strategy—called dose escalation—reduces nausea and digestive symptoms while allowing your body to adapt. Understanding how dosing works helps you get the most benefit from treatment.
How Semaglutide Dosing Schedules Work
Semaglutide injections use a four-week titration phase during which your dose increases weekly. Week one starts at 0.25 mg, week two moves to 0.5 mg, week three reaches 0.75 mg, and week four reaches 1.0 mg. This structured approach mirrors clinical trial protocols that demonstrated safe, effective weight reduction. Most patients remain on the 1.0 mg weekly dose long-term, though some require higher amounts.
The reason for starting low is straightforward: your gastrointestinal system needs time to adjust to semaglutide's appetite-suppressing mechanism. Jumping to a full dose immediately typically causes significant nausea, vomiting, and constipation. By spacing increases across four weeks, your body gradually becomes accustomed to the medication. PlexusDx provides clear guidance on when to advance each week based on your tolerability.
What Happens at the Maintenance Dose Level
Once you reach the 1.0 mg weekly maintenance dose, most patients stay at that strength indefinitely—unless their clinician recommends going higher. At this dose, clinical trials showed average weight loss of 5–10% of starting body weight over six months. Some patients achieve 15% or greater reductions, depending on their genetics, metabolism, and lifestyle. PlexusDx's Precision Peptide Genetic Test examines variants in the GLP1R gene (specifically rs6923761) and other pathways that predict individual dosing needs and weight loss response.
If plateau occurs—meaning weight loss stalls after several months—your clinician may increase to 1.7 mg or 2.0 mg weekly. These higher maintenance doses exist for patients who need additional appetite suppression or metabolic benefit. PlexusDx pricing remains flat regardless of which dose you use, so your monthly cost doesn't change as your prescription advances.
Managing Side Effects During Dose Escalation
Nausea is the most common side effect during the first two weeks, affecting up to 40% of users. This typically peaks within 24–48 hours after injection and subsides within a few days. Eating small, frequent meals; staying hydrated; and avoiding fatty or greasy foods reduces nausea intensity. If severe nausea persists, your clinician may pause the dose increase for an extra week—a practice called dose hold—before advancing further.
Constipation, the second most frequent side effect, stems from semaglutide slowing your gut motility to increase satiety. Increasing fiber intake gradually, drinking 8–10 glasses of water daily, and adding gentle movement like walking helps prevent constipation. Most patients find that starting low and titrating slowly—rather than jumping to high doses—keeps digestive side effects manageable and tolerable throughout treatment.
Personalized Dosing With PlexusDx Genetic Insights
Every person's body responds differently to semaglutide because of genetic variation in appetite-regulating pathways. PlexusDx's Precision Peptide Genetic Test identifies your unique genetic profile across 14 pathways and 49 peptides involved in weight regulation and GLP-1 response. The test examines key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—all of which influence how well semaglutide works for you. This genetic roadmap helps your clinician decide whether you'll benefit most from staying at standard 1.0 mg or advancing sooner to higher doses.
PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month of treatment, ensuring you've started therapy safely before testing. Results guide your titration path, potentially shortening the time to reach your optimal therapeutic dose. With genetic insights, your dosing plan becomes truly personalized rather than one-size-fits-all, improving your chances of achieving meaningful weight loss.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
Semaglutide for weight loss starts at 0.25 mg injected once weekly, then increases by 0.25 mg each week for four weeks until reaching the standard 1.0 mg maintenance dose. This gradual titration reduces nausea and allows your body to adjust to the medication safely.
Can you skip a dose increase or stay at a lower dose longer?
Yes. If side effects are bothersome, your clinician can pause the titration for one to two weeks before advancing to the next dose—a strategy called a dose hold. Some patients also remain long-term at 0.5 mg or 0.75 mg if they achieve good weight loss and tolerability at those levels.
How much does PlexusDx compounded semaglutide cost per month?
PlexusDx compounded semaglutide injection starts at $149 per month and remains flat regardless of which dose you take—whether 0.25 mg, 1.0 mg, or higher. PlexusDx serves all 50 states with no insurance required, and the medication is HSA/FSA eligible.
What happens if semaglutide stops working after several months?
Weight loss plateaus sometimes occur after 4–6 months on a stable dose. Your clinician may increase to 1.7 mg or 2.0 mg weekly to provide additional appetite suppression. PlexusDx's flat monthly pricing means a dose increase won't raise your monthly cost.
How can genetic testing help with semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across appetite pathways, including GLP1R and GIPR variants that predict your semaglutide response. This information helps your clinician personalize your titration schedule and target dose for better outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Science of Weight Management: How Does Wegovy Drug Work?
Navigating Your Zepbound Journey: Can You Take Zepbound Every Two Weeks?